RT Journal Article
SR Electronic
T1 Using a Novel Digital Go/No-Go to Dissociate Intra-subject Temporal Fluctuations in Reaction Time and Accuracy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.12.24308834
DO 10.1101/2024.06.12.24308834
A1 Nguyen, Theresa M.
A1 Ross, Mindy K.
A1 Ning, Emma
A1 Kabir, Sarah
A1 Cladek, Andrea T.
A1 Barve, Amruta
A1 Kennelly, Ellyn
A1 Hussain, Faraz
A1 Duffecy, Jennifer
A1 Langenecker, Scott L.
A1 Zulueta, John
A1 Demos, Alexander P.
A1 Ajilore, Olusola A.
A1 Leow, Alex D.
YR 2024
UL http://medrxiv.org/content/early/2024/06/13/2024.06.12.24308834.abstract
AB Impulsivity can be a risk factor for serious complications for those with mood disorders. To understand intra-individual impulsivity variability, we analyzed longitudinal data of a novel gamified digital Go/No-Go (GNG) task in a clinical sample (n=43 mood disorder participants, n=17 healthy controls) and an open-science sample (n=121, self-reported diagnoses). With repeated measurements within-subject, we disentangled two aspects of GNG: reaction time and accuracy in response inhibition (i.e., incorrect No-Go trials) with respect to diurnal and potential learning effects. Mixed-effects models showed diurnal effects in reaction time but not accuracy, with a significant effect of hour on reaction time in the clinical sample and the open-science sample. Moreover, subjects improved on their response inhibition but not reaction time. Additionally, significant interactions emerged between depression symptom severity and time-of-day in both samples, supporting that repeated administration of our GNG task can yield mood-dependent circadian rhythm-aware biomarkers of neurocognitive function.Competing Interest StatementA.D.L. reports being a cofounder of KeyWise AI, serving on the medical advisory board for digital medicine for Otsuka, USA and Buoy Health. O.A.A. reports being a cofounder of KeyWise AI, a consultant of Otsuka USA, and serving on the advisory board of Embodied Labs, Sage Therapeutics, and Blueprint Health.Funding StatementThis research was funded by the National Institute of Mental Health of the National Institutes of Health (NIMH-NIH), R01MH120186.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Office for the Protection of Research Subjects of University of Illinois at Chicago gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data will be available on the NIMH Data Archive.